Career records & work history
License Records
Jian Ming Gu
Licenses:
License #: MT-0003485 - Expired
Category: Massage Bodywork
Type: Licensed Massage Therapist
Category: Massage Bodywork
Type: Licensed Massage Therapist
Jian D Gu, 632618 Tillman Dr, Arlington, TX 76006
Jian Gu Phones & Addresses
2618 Tillman Dr, Arlington, TX 76006 817-6497791
Dallas, TX
Canoga Park, CA
Flushing, NY
Teaneck, NJ
2618 Tillman Dr, Arlington, TX 76006 817-2475535
Work
Position:
Sales Occupations
Education
Degree:
High school graduate or higher
Emails
Mentions for Jian D Gu
Jian Gu resumes & CV records
Resumes
Mechanical Engineer
Location:
Dallas, TX
Industry:
Telecommunications
Work:
Nokia
1997 - 2013
Mechanical Specialist Nokia 1997 - 2013
Mechanical Engineer
Mechanical Specialist Nokia 1997 - 2013
Mechanical Engineer
Skills:
Testing, Telecommunications, Product Development, Wireless, Engineering, Management, Gsm, Mobile Devices, Lte, Product Management, Mobile Communications, Team Leadership
Jian Gu
Jian Gu
Cto At Risecomm
Position:
CTO at Risecomm
Location:
Other
Industry:
Electrical/Electronic Manufacturing
Work:
Risecomm
since Oct 2003
CTO 4D Connect 2000 - 2003
President CommQuest 1997 - 2000
Technical Director Commquest/IBM 1994 - 2000
Technical Director CommQuest Technologies 1994 - 2000
Technical Director Zhejiang University Nov 1984 - Sep 1987
Faculty member
CTO 4D Connect 2000 - 2003
President CommQuest 1997 - 2000
Technical Director Commquest/IBM 1994 - 2000
Technical Director CommQuest Technologies 1994 - 2000
Technical Director Zhejiang University Nov 1984 - Sep 1987
Faculty member
Education:
Georgia Institute of Technology 1993 - 1994
Post-Doc Researcher, Electrical Engineering University of Maryland College Park 1987 - 1993
PH. D., Electrical Engineering Zhejiang University 1982 - 1984
Master of Science (M.S.), Electrical Engineering Zhejiang University 1978 - 1982
Bachelor of Science (B.S.), Mathematics
Post-Doc Researcher, Electrical Engineering University of Maryland College Park 1987 - 1993
PH. D., Electrical Engineering Zhejiang University 1982 - 1984
Master of Science (M.S.), Electrical Engineering Zhejiang University 1978 - 1982
Bachelor of Science (B.S.), Mathematics
At Genscript
Position:
Research Fellow at Genscript
Location:
Dallas/Fort Worth Area
Industry:
Biotechnology
Work:
Genscript
since Oct 2009
Research Fellow Osmetech Molecular Diagnostics 2008 - 2009
Principal Scientist Biosynthesis Inc 1998 - 2008
Senior scientist, group leader
Research Fellow Osmetech Molecular Diagnostics 2008 - 2009
Principal Scientist Biosynthesis Inc 1998 - 2008
Senior scientist, group leader
Education:
Shanghai Institute of Materia Medic, Chinese Academy of 1984 - 1989
Skills:
LC-MS, NMR, HPLC, Chemistry
Publications & IP owners
Us Patents
Biodegradable Sustained-Release Alginate Gels
US Patent:
6432449, Aug 13, 2002
Filed:
May 18, 1998
Appl. No.:
09/080832
Inventors:
Merrill Seymour Goldenberg - Thousand Oaks CA
Jian Hua Gu - Thousand Oaks CA
Jian Hua Gu - Thousand Oaks CA
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 910
US Classification:
424486, 424426, 514944, 514909, 514779
Abstract:
The present invention relates to sustained-release formulations using biodegradable alginate delayed gels or particles and methods thereof.
Sustained Release Formulations
US Patent:
7323169, Jan 29, 2008
Filed:
Apr 25, 2005
Appl. No.:
11/114473
Inventors:
Merrill S. Goldenberg - Thousand Oaks CA, US
Jian Hua Gu - Thousand Oaks CA, US
Jian Hua Gu - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 8/37
A61K 38/02
A61K 38/08
A61K 39/395
A61K 38/02
A61K 38/08
A61K 39/395
US Classification:
4241301, 514 2, 514 15, 514785
Abstract:
The present invention relates broadly to the field of sustained release formulations. More specifically, the invention describes compositions and methods relating to formulating proteins and/or peptides with purified gallic acid esters. In one example, the gallic acid ester is PentaGalloylGlucose (PGG) and in anther example the gallic acid ester is epigallocatechin gallate (EGCG).
Sustained Release Formulations
US Patent:
7732399, Jun 8, 2010
Filed:
Aug 30, 2007
Appl. No.:
11/847984
Inventors:
Merrill S. Goldenberg - Thousand Oaks CA, US
Jian Hua Gu - Thousand Oaks CA, US
Jian Hua Gu - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 38/02
A61K 38/03
A61K 38/08
A61K 47/14
A61K 38/03
A61K 38/08
A61K 47/14
US Classification:
514 2, 514 15, 514785
Abstract:
The present invention relates broadly to the field of sustained release formulations. More specifically, the invention describes compositions and methods relating to formulating proteins and/or peptides with purified gallic acid esters. In one example, the gallic acid ester is PentaGalloylGlucose (PGG) and in anther example the gallic acid ester is epigallocatechin gallate (EGCG).
Sustained-Release Delayed Gels
US Patent:
2001000, Jul 12, 2001
Filed:
Nov 12, 1999
Appl. No.:
09/423779
Inventors:
MERRILL SEYMOUR GOLDENBERG - THOUSAND OAKS CA, US
ALICE C. BEEKMAN - THOUSAND OAKS CA, US
JIAN GU - THOUSAND OAKS CA, US
ALICE C. BEEKMAN - THOUSAND OAKS CA, US
JIAN GU - THOUSAND OAKS CA, US
International Classification:
A61K009/00
US Classification:
424/400000
Abstract:
The present invention relates to sustained-release formulations using alginate delayed gels and methods thereof.
Biodegradable Sustained-Release Alginate Gels
US Patent:
2002016, Nov 14, 2002
Filed:
Jun 20, 2002
Appl. No.:
10/176768
Inventors:
Merrill Goldenberg - Thousand Oaks CA, US
Jian Gu - Thousand Oaks CA, US
Jian Gu - Thousand Oaks CA, US
International Classification:
A61K009/22
US Classification:
424/468000
Abstract:
The present invention relates to sustained-release formulations using biodegradable alginate delayed gels or particles and methods thereof.
Sustained-Release Delayed Gels
US Patent:
2003007, Apr 17, 2003
Filed:
Nov 20, 2002
Appl. No.:
10/301360
Inventors:
Merrill Goldenberg - Thousand Oaks CA, US
Alice Beekman - Thousand Oaks CA, US
Jian Gu - Thousand Oaks CA, US
Alice Beekman - Thousand Oaks CA, US
Jian Gu - Thousand Oaks CA, US
Assignee:
Amgen Inc.
International Classification:
A61K009/22
US Classification:
424/468000
Abstract:
The present invention relates to sustained-release formulations using alginate delayed gels and methods thereof.
Formulations Of Human Anti-Rankl Antibodies, And Methods Of Using The Same
US Patent:
2020035, Nov 12, 2020
Filed:
Apr 27, 2018
Appl. No.:
16/608375
Inventors:
- Thousand Oaks CA, US
Lyanne M. Wong - Valencia CA, US
Jaymille Fallon - Agoura Hills CA, US
Monica Michelle Goss - Newbury Park CA, US
Jian Hua Gu - Thousand Oaks CA, US
Lyanne M. Wong - Valencia CA, US
Jaymille Fallon - Agoura Hills CA, US
Monica Michelle Goss - Newbury Park CA, US
Jian Hua Gu - Thousand Oaks CA, US
International Classification:
C07K 16/28
Abstract:
Disclosed herein are aqueous pharmaceutical formulations comprising denosumab or another human anti-RANKL monoclonal antibody or portion thereof, and characteristics of pH, buffer systems, and amino acid aggregation inhibitors. Also disclosed are presentation of the formulation for use, e.g. in a single-use vial, single-use syringe, or glass container, methods of using the formulations and articles for preventing or treating diseases, and related kits.
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.